Navigation Links
Responses After Completion of Therapy Increase Pixantrone Complete Remission (CR)/Unconfirmed Complete Remission (CRu) Rate to 24% and Overall Response Rate (ORR) to 40% Compared to 7% and 14% for Comparator Agents in Phase III EXTEND Trial in 3rd Line Th
Date:6/21/2009

ts) for those that received standard chemotherapy.

"It is gratifying that we are seeing more patients convert to complete remission after the initial assessment period with pixantrone compared to other agents. These additional late responders are likely to have a positive impact on analyses of progression free and overall survival and will be provided to the U.S. Food and Drug Administration during the 120-day update," stated James A. Bianco, M.D., Chief Executive Officer of CTI. "We plan to request priority review of the NDA from the FDA as we believe that pixantrone would provide patients and physicians with a compelling new option in treating this disease."

Review of Pixantrone Clinical Studies in Indolent non-Hodgkin's lymphoma

Additionally, data from two previously reported clinical trials investigating pixantrone combined with other agents in indolent NHL is being reviewed. In one trial, PIX 302, patients that received pixantrone plus rituximab achieved higher CR and ORR rates, (CR=35% (7 of 20 patients); ORR=75% (15 of 20 patients)) as well as a longer TTP (13.2 months) than those who only received rituximab alone (CR=11% (2 of 18 patients); ORR=33% (6 of 18 patients); TTP=8.1 months) in relapsed/refractory indolent NHL. In a separate study, AZA I06, pixantrone and the FPD-R regimen achieved high response rates (CR/CRu=70% (19 of 27 patients); ORR=89% (24 of 27 patients) in relapsed/refractory indolent NHL, nearly all of whom had received aggressive first-line therapy with CHOP-R.

The Pan Pacific Lymphoma Conference poster is available at http://www.celltherapeutics.com/investor_updates.

About the PIX 301 EXTEND Trial

The PIX 301 EXTEND trial was a phase III single-agent trial of pixantrone for patients with relapsed or refractory, aggressive NHL who received two or more
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Preclinical Study Presented at AACR Annual Meeting Shows Peregrines Anti-PS Immunocytokines Can Generate Protective Immune Responses in a Highly Aggressive Breast Cancer Model
2. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
3. Micromets BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkins Lymphoma
4. SARS Vaccine Achieves Neutralizing Responses in First U.S. Human Trial
5. Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans
6. Use it or Lose it: A New Theory About Preserving Erectile Function After Prostate Surgery
7. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
8. Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept)
9. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
10. AHF Seeks White House Clarification After Press Room Flap Over CDCs HIV Numbers
11. New Implantable Lenses Can Reduce the Need for Glasses After Cataract Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 30, 2015  Amgen (NASDAQ: AMGN ) today announced ... director of Warburg Pincus LLC, to the Amgen Board of ... Fred Hassan and the deep, global experience he brings ... Robert A. Bradway , chairman and chief executive officer of Amgen. ... serve Amgen well." Mr. Hassan has been Partner ...
(Date:7/30/2015)... 2015  Cleveland Clinic President Wael Barsoum , ... month that industry is compelled to adopt declining reimbursements ... efficiencies—and develop the transformational innovations -- required to thrive ... preceded by Doug Kohrs , past President and ... stressed that industry must add "episode of care," also ...
(Date:7/30/2015)... 2015  Growth of the U.S. nonprescription market is ... prescription users to the OTC market. Due to an ... Rx-to-OTC switch activity over the next five years with ... new brands entering the market into existing categories. ... years (even those with low to moderate likelihood), the ...
Breaking Medicine Technology:Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3
(Date:8/1/2015)... ... ... Back packs can be dangerous? Whaaat?! , Not the danger that guns and ... kid's spine. With school starting again, most kids will be asking for new backpacks ... of how to help them prevent injuries by understanding backpack safety. , "Carrying more ...
(Date:8/1/2015)... NY (PRWEB) , ... August 01, 2015 , ... Calvary ... scroll currently housed at their Bronx campus. The goal is to bring this Torah ... again be used in Jewish rituals and religious services. , Scroll No. 515, ...
(Date:8/1/2015)... ... August 01, 2015 , ... On Tuesday, July 28th, Symantec released ... thought to have been behind the attack on Anthem Inc. which resulted in one ... exploits, watering hole attacks and spear phishing campaigns. , For Joe Caruso, ...
(Date:8/1/2015)... ... ... Phil Valentine – the Executive Director of Connecticut Community for Addiction Recovery (CCAR) – began ... and heading north. Since that day, Phil has hiked over 1400 miles in nine states. ... family. He visited CCAR and left an inspirational message to his staff: “You can ...
(Date:7/31/2015)... Indianapolis, Ind. (PRWEB) , ... August 01, 2015 , ... ... of the Global Advisory Panel on the Future of Nursing (GAPFON) 20-21 July 2015 ... were invited to participate in this meeting. , Dr. Silvia Cassiani, Advisor, Nursing and ...
Breaking Medicine News(10 mins):Health News:Local AlignLife Doctor Donates Time to Check Back Packs 2Health News:Calvary Hospital Announces Plans to Restore Historic Torah 2Health News:Calvary Hospital Announces Plans to Restore Historic Torah 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 2Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 4Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4
... Free Online Tool Increases Physical ActivitySACRAMENTO, Calif., Jan. 13 ... active lifestyle is just a few clicks away with ... reduce the risk of chronic diseases like type 2 ... of all American women (47.7 percent) engage in at ...
... or exceed The Joint Commission,s OPPE and FPPE ... today announced two new services to help hospitals ... the performance of their physicians, as well as ... hospitals meet ongoing professional practice evaluation (OPPE) and ...
... Connect(TM) links health plan, physicians and community ... Jan. 13 Health Integrated, a pioneer ... people with chronic illnesses get the most ... Health Integrated,s groundbreaking Synergy Connect(TM) service actively ...
... serve as an affiliate sponsor of Alegra Motorsports during the 2009 GrandAm ... ... 2009 -- TodayMD , the nations leading medical internet marketing ... Motorsports one of the sponsors of the No. 22 car driven by ...
... Runway Collection by America,s Leading Fashion Designer Michael Kors, Will ... 13 The Buoniconti Fund to Cure Paralysis ... Grammy winner Seal will be the musical headliner ... at Bal Harbour Shops. The legendary Pointer Sisters ...
... case that could,affect one-third of American families, Cook County ... 10 month old child with a severe heart,condition to ... gave the,father custody of his 3 year old biological ... because most courts have not recognized stepfathers,as having any ...
Cached Medicine News:Health News:MyFitness Planner Really Moves You 2Health News:AllMed Announces PeerScore Solutions for Hospital Peer Review 2Health News:AllMed Announces PeerScore Solutions for Hospital Peer Review 3Health News:Health Integrated Unifies Care Community to Improve Physical, Psychological and Social Health of the Chronically Ill 2Health News:Health Integrated Unifies Care Community to Improve Physical, Psychological and Social Health of the Chronically Ill 3Health News:TodayMD Renews Race Sponsorship With Alegra Motorsports For A Third Year 2Health News:TodayMD Renews Race Sponsorship With Alegra Motorsports For A Third Year 3Health News:Multi-Platinum Recording Artist Seal Announced as Headliner for Destination Fashion 2009 Benefiting The Buoniconti Fund to Cure Paralysis 2
... Elutra Cell Separation System is ... you to separate cell populations ... both size and density. This ... cell enrichment, depletion, concentration, and ...
... Distriman is a ... that is designed to ... used with Gilson DistriTip ... polypropylene syringes with level ...
... catheters are lightweight and balanced for smooth, ... feel and comfort, reducing fatigue in even ... allows a physician to easily steer the ... with just one finger. Reflexion's auto-lock technology ...
... - Quantum™ LEAP® balloon material and ... in the Quantum™ Maverick® Balloon Catheter ... balloon with exceptional deliverability. Easier to ... technology improves trackability and crossability through; ...
Medicine Products: